- Home
- BRT vs KRRO Comparison
BRT vs KRRO Comparison
Compare BRT & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRT
- KRRO
- Stock Information
- Founded
- BRT 1972
- KRRO 2014
- Country
- BRT United States
- KRRO United States
- Employees
- BRT N/A
- KRRO N/A
- Industry
- BRT Real Estate Investment Trusts
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- BRT Real Estate
- KRRO Health Care
- Exchange
- BRT Nasdaq
- KRRO Nasdaq
- Market Cap
- BRT 331.7M
- KRRO 281.2M
- IPO Year
- BRT N/A
- KRRO 2019
- Fundamental
- Price
- BRT $17.50
- KRRO $26.29
- Analyst Decision
- BRT Strong Buy
- KRRO Strong Buy
- Analyst Count
- BRT 3
- KRRO 7
- Target Price
- BRT $22.17
- KRRO $133.83
- AVG Volume (30 Days)
- BRT 17.3K
- KRRO 61.9K
- Earning Date
- BRT 03-11-2025
- KRRO 03-25-2025
- Dividend Yield
- BRT 5.71%
- KRRO N/A
- EPS Growth
- BRT N/A
- KRRO N/A
- EPS
- BRT N/A
- KRRO N/A
- Revenue
- BRT $96,743,000.00
- KRRO N/A
- Revenue This Year
- BRT N/A
- KRRO N/A
- Revenue Next Year
- BRT $5.73
- KRRO N/A
- P/E Ratio
- BRT N/A
- KRRO N/A
- Revenue Growth
- BRT 1.95
- KRRO N/A
- 52 Week Low
- BRT $15.21
- KRRO $26.23
- 52 Week High
- BRT $20.22
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- BRT 46.94
- KRRO 29.17
- Support Level
- BRT $17.54
- KRRO $28.90
- Resistance Level
- BRT $18.26
- KRRO $40.68
- Average True Range (ATR)
- BRT 0.45
- KRRO 2.26
- MACD
- BRT 0.04
- KRRO -0.36
- Stochastic Oscillator
- BRT 46.48
- KRRO 0.42
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is primarily focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.